nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—CYP3A4—Methylprednisolone—psoriatic arthritis	0.124	0.248	CbGbCtD
Pimecrolimus—CYP3A4—Triamcinolone—psoriatic arthritis	0.094	0.188	CbGbCtD
Pimecrolimus—CYP3A4—Betamethasone—psoriatic arthritis	0.0806	0.161	CbGbCtD
Pimecrolimus—CYP3A4—Prednisolone—psoriatic arthritis	0.0796	0.159	CbGbCtD
Pimecrolimus—CYP3A4—Prednisone—psoriatic arthritis	0.0751	0.15	CbGbCtD
Pimecrolimus—CYP3A4—Dexamethasone—psoriatic arthritis	0.0469	0.0938	CbGbCtD
Pimecrolimus—Skin atrophy—Prednisone—psoriatic arthritis	0.00752	0.0151	CcSEcCtD
Pimecrolimus—Leukoderma—Prednisolone—psoriatic arthritis	0.00736	0.0147	CcSEcCtD
Pimecrolimus—Leukaemia—Methotrexate—psoriatic arthritis	0.00705	0.0141	CcSEcCtD
Pimecrolimus—Ear infection—Triamcinolone—psoriatic arthritis	0.00676	0.0135	CcSEcCtD
Pimecrolimus—Leukoderma—Triamcinolone—psoriatic arthritis	0.00676	0.0135	CcSEcCtD
Pimecrolimus—Leukoderma—Methylprednisolone—psoriatic arthritis	0.00675	0.0135	CcSEcCtD
Pimecrolimus—Leukoderma—Dexamethasone—psoriatic arthritis	0.00614	0.0123	CcSEcCtD
Pimecrolimus—Leukoderma—Betamethasone—psoriatic arthritis	0.00614	0.0123	CcSEcCtD
Pimecrolimus—Application site reaction—Triamcinolone—psoriatic arthritis	0.00613	0.0123	CcSEcCtD
Pimecrolimus—Sinus congestion—Triamcinolone—psoriatic arthritis	0.00578	0.0116	CcSEcCtD
Pimecrolimus—Lymphoma—Methotrexate—psoriatic arthritis	0.00544	0.0109	CcSEcCtD
Pimecrolimus—Leukoderma—Prednisone—psoriatic arthritis	0.00535	0.0107	CcSEcCtD
Pimecrolimus—Conjunctivitis—Auranofin—psoriatic arthritis	0.00533	0.0107	CcSEcCtD
Pimecrolimus—Skin hyperpigmentation—Triamcinolone—psoriatic arthritis	0.00483	0.00967	CcSEcCtD
Pimecrolimus—Skin hyperpigmentation—Methylprednisolone—psoriatic arthritis	0.00482	0.00965	CcSEcCtD
Pimecrolimus—Eye disorder—Auranofin—psoriatic arthritis	0.0046	0.00921	CcSEcCtD
Pimecrolimus—Folliculitis—Triamcinolone—psoriatic arthritis	0.00458	0.00915	CcSEcCtD
Pimecrolimus—Folliculitis—Methylprednisolone—psoriatic arthritis	0.00457	0.00913	CcSEcCtD
Pimecrolimus—Leukoderma—Methotrexate—psoriatic arthritis	0.00447	0.00894	CcSEcCtD
Pimecrolimus—Skin hyperpigmentation—Dexamethasone—psoriatic arthritis	0.00439	0.00878	CcSEcCtD
Pimecrolimus—Skin hyperpigmentation—Betamethasone—psoriatic arthritis	0.00439	0.00878	CcSEcCtD
Pimecrolimus—Folliculitis—Dexamethasone—psoriatic arthritis	0.00415	0.00831	CcSEcCtD
Pimecrolimus—Folliculitis—Betamethasone—psoriatic arthritis	0.00415	0.00831	CcSEcCtD
Pimecrolimus—Bacterial infection—Methotrexate—psoriatic arthritis	0.00411	0.00823	CcSEcCtD
Pimecrolimus—Throat sore—Triamcinolone—psoriatic arthritis	0.00399	0.00798	CcSEcCtD
Pimecrolimus—Oropharyngeal discomfort—Triamcinolone—psoriatic arthritis	0.00395	0.00791	CcSEcCtD
Pimecrolimus—Angioedema—Auranofin—psoriatic arthritis	0.00392	0.00784	CcSEcCtD
Pimecrolimus—Furuncle—Methotrexate—psoriatic arthritis	0.00387	0.00775	CcSEcCtD
Pimecrolimus—Acne—Prednisolone—psoriatic arthritis	0.00372	0.00744	CcSEcCtD
Pimecrolimus—Eye irritation—Prednisolone—psoriatic arthritis	0.00366	0.00733	CcSEcCtD
Pimecrolimus—Viral infection—Prednisolone—psoriatic arthritis	0.00346	0.00693	CcSEcCtD
Pimecrolimus—Acne—Triamcinolone—psoriatic arthritis	0.00342	0.00684	CcSEcCtD
Pimecrolimus—Acne—Methylprednisolone—psoriatic arthritis	0.00341	0.00682	CcSEcCtD
Pimecrolimus—Herpes simplex—Prednisolone—psoriatic arthritis	0.00339	0.00679	CcSEcCtD
Pimecrolimus—Skin hyperpigmentation—Methotrexate—psoriatic arthritis	0.00319	0.00639	CcSEcCtD
Pimecrolimus—Dysmenorrhoea—Triamcinolone—psoriatic arthritis	0.00316	0.00633	CcSEcCtD
Pimecrolimus—Oropharyngeal pain—Triamcinolone—psoriatic arthritis	0.00316	0.00633	CcSEcCtD
Pimecrolimus—Acne—Betamethasone—psoriatic arthritis	0.0031	0.0062	CcSEcCtD
Pimecrolimus—Acne—Dexamethasone—psoriatic arthritis	0.0031	0.0062	CcSEcCtD
Pimecrolimus—Folliculitis—Methotrexate—psoriatic arthritis	0.00302	0.00605	CcSEcCtD
Pimecrolimus—Constipation—Auranofin—psoriatic arthritis	0.00299	0.00599	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00286	0.00573	CcSEcCtD
Pimecrolimus—Herpes simplex—Dexamethasone—psoriatic arthritis	0.00283	0.00567	CcSEcCtD
Pimecrolimus—Herpes simplex—Betamethasone—psoriatic arthritis	0.00283	0.00567	CcSEcCtD
Pimecrolimus—Wheezing—Triamcinolone—psoriatic arthritis	0.00279	0.00559	CcSEcCtD
Pimecrolimus—Urticaria—Auranofin—psoriatic arthritis	0.00278	0.00556	CcSEcCtD
Pimecrolimus—Abdominal pain—Auranofin—psoriatic arthritis	0.00277	0.00553	CcSEcCtD
Pimecrolimus—Skin exfoliation—Triamcinolone—psoriatic arthritis	0.00275	0.00549	CcSEcCtD
Pimecrolimus—Skin exfoliation—Methylprednisolone—psoriatic arthritis	0.00274	0.00548	CcSEcCtD
Pimecrolimus—Acne—Prednisone—psoriatic arthritis	0.0027	0.0054	CcSEcCtD
Pimecrolimus—Viral infection—Prednisone—psoriatic arthritis	0.00252	0.00503	CcSEcCtD
Pimecrolimus—Skin exfoliation—Dexamethasone—psoriatic arthritis	0.00249	0.00498	CcSEcCtD
Pimecrolimus—Skin exfoliation—Betamethasone—psoriatic arthritis	0.00249	0.00498	CcSEcCtD
Pimecrolimus—Pruritus—Auranofin—psoriatic arthritis	0.00248	0.00495	CcSEcCtD
Pimecrolimus—Diarrhoea—Auranofin—psoriatic arthritis	0.00239	0.00479	CcSEcCtD
Pimecrolimus—Vomiting—Auranofin—psoriatic arthritis	0.00222	0.00445	CcSEcCtD
Pimecrolimus—Rash—Auranofin—psoriatic arthritis	0.00221	0.00441	CcSEcCtD
Pimecrolimus—Dermatitis—Auranofin—psoriatic arthritis	0.0022	0.00441	CcSEcCtD
Pimecrolimus—Skin exfoliation—Prednisone—psoriatic arthritis	0.00217	0.00434	CcSEcCtD
Pimecrolimus—Skin discolouration—Methotrexate—psoriatic arthritis	0.0021	0.00421	CcSEcCtD
Pimecrolimus—Bone disorder—Methotrexate—psoriatic arthritis	0.0021	0.00421	CcSEcCtD
Pimecrolimus—Nausea—Auranofin—psoriatic arthritis	0.00208	0.00416	CcSEcCtD
Pimecrolimus—Herpes simplex—Methotrexate—psoriatic arthritis	0.00206	0.00412	CcSEcCtD
Pimecrolimus—Breast disorder—Methylprednisolone—psoriatic arthritis	0.00188	0.00377	CcSEcCtD
Pimecrolimus—Skin exfoliation—Methotrexate—psoriatic arthritis	0.00181	0.00363	CcSEcCtD
Pimecrolimus—Asthma—Triamcinolone—psoriatic arthritis	0.0018	0.00361	CcSEcCtD
Pimecrolimus—Influenza—Triamcinolone—psoriatic arthritis	0.0018	0.00361	CcSEcCtD
Pimecrolimus—Bronchitis—Triamcinolone—psoriatic arthritis	0.00174	0.00347	CcSEcCtD
Pimecrolimus—Conjunctivitis—Prednisolone—psoriatic arthritis	0.0017	0.0034	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00168	0.00336	CcSEcCtD
Pimecrolimus—Infestation—Methylprednisolone—psoriatic arthritis	0.00161	0.00321	CcSEcCtD
Pimecrolimus—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00161	0.00321	CcSEcCtD
Pimecrolimus—Face oedema—Prednisone—psoriatic arthritis	0.00159	0.00319	CcSEcCtD
Pimecrolimus—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00156	0.00313	CcSEcCtD
Pimecrolimus—Epistaxis—Triamcinolone—psoriatic arthritis	0.00152	0.00304	CcSEcCtD
Pimecrolimus—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.00146	0.00292	CcSEcCtD
Pimecrolimus—Rhinitis—Triamcinolone—psoriatic arthritis	0.00145	0.0029	CcSEcCtD
Pimecrolimus—Rhinitis—Methylprednisolone—psoriatic arthritis	0.00144	0.00289	CcSEcCtD
Pimecrolimus—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00143	0.00287	CcSEcCtD
Pimecrolimus—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.00142	0.00284	CcSEcCtD
Pimecrolimus—Conjunctivitis—Betamethasone—psoriatic arthritis	0.00142	0.00284	CcSEcCtD
Pimecrolimus—Erythema—Prednisolone—psoriatic arthritis	0.00137	0.00274	CcSEcCtD
Pimecrolimus—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00135	0.00269	CcSEcCtD
Pimecrolimus—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.0013	0.0026	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.0013	0.0026	CcSEcCtD
Pimecrolimus—Erythema—Triamcinolone—psoriatic arthritis	0.00126	0.00252	CcSEcCtD
Pimecrolimus—Erythema—Methylprednisolone—psoriatic arthritis	0.00125	0.00251	CcSEcCtD
Pimecrolimus—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00125	0.00251	CcSEcCtD
Pimecrolimus—Angioedema—Prednisolone—psoriatic arthritis	0.00125	0.0025	CcSEcCtD
Pimecrolimus—Breast disorder—Methotrexate—psoriatic arthritis	0.00125	0.00249	CcSEcCtD
Pimecrolimus—Eye disorder—Dexamethasone—psoriatic arthritis	0.00122	0.00245	CcSEcCtD
Pimecrolimus—Eye disorder—Betamethasone—psoriatic arthritis	0.00122	0.00245	CcSEcCtD
Pimecrolimus—Back pain—Triamcinolone—psoriatic arthritis	0.00122	0.00243	CcSEcCtD
Pimecrolimus—Asthma—Methotrexate—psoriatic arthritis	0.00119	0.00238	CcSEcCtD
Pimecrolimus—Angioedema—Triamcinolone—psoriatic arthritis	0.00115	0.0023	CcSEcCtD
Pimecrolimus—Angioedema—Methylprednisolone—psoriatic arthritis	0.00115	0.00229	CcSEcCtD
Pimecrolimus—Erythema—Dexamethasone—psoriatic arthritis	0.00114	0.00228	CcSEcCtD
Pimecrolimus—Erythema—Betamethasone—psoriatic arthritis	0.00114	0.00228	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00112	0.00223	CcSEcCtD
Pimecrolimus—Oedema—Prednisolone—psoriatic arthritis	0.00112	0.00223	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00111	0.00222	CcSEcCtD
Pimecrolimus—Cough—Triamcinolone—psoriatic arthritis	0.0011	0.0022	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00109	0.00218	CcSEcCtD
Pimecrolimus—Pneumonia—Methotrexate—psoriatic arthritis	0.00107	0.00214	CcSEcCtD
Pimecrolimus—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00107	0.00214	CcSEcCtD
Pimecrolimus—Eye disorder—Prednisone—psoriatic arthritis	0.00107	0.00213	CcSEcCtD
Pimecrolimus—Infestation NOS—Methotrexate—psoriatic arthritis	0.00106	0.00213	CcSEcCtD
Pimecrolimus—Infestation—Methotrexate—psoriatic arthritis	0.00106	0.00213	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00106	0.00212	CcSEcCtD
Pimecrolimus—Flushing—Prednisone—psoriatic arthritis	0.00106	0.00212	CcSEcCtD
Pimecrolimus—Angioedema—Dexamethasone—psoriatic arthritis	0.00104	0.00209	CcSEcCtD
Pimecrolimus—Angioedema—Betamethasone—psoriatic arthritis	0.00104	0.00209	CcSEcCtD
Pimecrolimus—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00103	0.00207	CcSEcCtD
Pimecrolimus—Immune system disorder—Prednisone—psoriatic arthritis	0.00103	0.00206	CcSEcCtD
Pimecrolimus—Oedema—Triamcinolone—psoriatic arthritis	0.00103	0.00205	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00103	0.00205	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00102	0.00205	CcSEcCtD
Pimecrolimus—Infection—Triamcinolone—psoriatic arthritis	0.00102	0.00204	CcSEcCtD
Pimecrolimus—Infection—Methylprednisolone—psoriatic arthritis	0.00102	0.00203	CcSEcCtD
Pimecrolimus—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.001	0.00201	CcSEcCtD
Pimecrolimus—Epistaxis—Methotrexate—psoriatic arthritis	0.001	0.002	CcSEcCtD
Pimecrolimus—Paraesthesia—Prednisolone—psoriatic arthritis	0.001	0.002	CcSEcCtD
Pimecrolimus—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000994	0.00199	CcSEcCtD
Pimecrolimus—Erythema—Prednisone—psoriatic arthritis	0.000993	0.00199	CcSEcCtD
Pimecrolimus—Malnutrition—Prednisone—psoriatic arthritis	0.000993	0.00199	CcSEcCtD
Pimecrolimus—Pain—Prednisolone—psoriatic arthritis	0.000954	0.00191	CcSEcCtD
Pimecrolimus—Pharyngitis—Methotrexate—psoriatic arthritis	0.000947	0.00189	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000935	0.00187	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000933	0.00187	CcSEcCtD
Pimecrolimus—Oedema—Betamethasone—psoriatic arthritis	0.000931	0.00186	CcSEcCtD
Pimecrolimus—Oedema—Dexamethasone—psoriatic arthritis	0.000931	0.00186	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000931	0.00186	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000931	0.00186	CcSEcCtD
Pimecrolimus—Infection—Dexamethasone—psoriatic arthritis	0.000925	0.00185	CcSEcCtD
Pimecrolimus—Infection—Betamethasone—psoriatic arthritis	0.000925	0.00185	CcSEcCtD
Pimecrolimus—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000921	0.00184	CcSEcCtD
Pimecrolimus—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000919	0.00184	CcSEcCtD
Pimecrolimus—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000915	0.00183	CcSEcCtD
Pimecrolimus—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000913	0.00183	CcSEcCtD
Pimecrolimus—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000913	0.00183	CcSEcCtD
Pimecrolimus—Angioedema—Prednisone—psoriatic arthritis	0.000908	0.00182	CcSEcCtD
Pimecrolimus—Eye disorder—Methotrexate—psoriatic arthritis	0.000891	0.00178	CcSEcCtD
Pimecrolimus—Urticaria—Prednisolone—psoriatic arthritis	0.000886	0.00177	CcSEcCtD
Pimecrolimus—Pain—Triamcinolone—psoriatic arthritis	0.000877	0.00176	CcSEcCtD
Pimecrolimus—Immune system disorder—Methotrexate—psoriatic arthritis	0.000861	0.00172	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00086	0.00172	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000848	0.0017	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000848	0.0017	CcSEcCtD
Pimecrolimus—Arthralgia—Prednisone—psoriatic arthritis	0.000846	0.00169	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00084	0.00168	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000837	0.00168	CcSEcCtD
Pimecrolimus—Paraesthesia—Betamethasone—psoriatic arthritis	0.000836	0.00167	CcSEcCtD
Pimecrolimus—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000836	0.00167	CcSEcCtD
Pimecrolimus—Erythema—Methotrexate—psoriatic arthritis	0.00083	0.00166	CcSEcCtD
Pimecrolimus—Malnutrition—Methotrexate—psoriatic arthritis	0.00083	0.00166	CcSEcCtD
Pimecrolimus—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000822	0.00164	CcSEcCtD
Pimecrolimus—Urticaria—Triamcinolone—psoriatic arthritis	0.000815	0.00163	CcSEcCtD
Pimecrolimus—Urticaria—Methylprednisolone—psoriatic arthritis	0.000813	0.00163	CcSEcCtD
Pimecrolimus—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000811	0.00162	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000811	0.00162	CcSEcCtD
Pimecrolimus—Oedema—Prednisone—psoriatic arthritis	0.000811	0.00162	CcSEcCtD
Pimecrolimus—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000809	0.00162	CcSEcCtD
Pimecrolimus—Infection—Prednisone—psoriatic arthritis	0.000805	0.00161	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000804	0.00161	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000804	0.00161	CcSEcCtD
Pimecrolimus—Back pain—Methotrexate—psoriatic arthritis	0.000803	0.00161	CcSEcCtD
Pimecrolimus—Pain—Betamethasone—psoriatic arthritis	0.000796	0.00159	CcSEcCtD
Pimecrolimus—Pain—Dexamethasone—psoriatic arthritis	0.000796	0.00159	CcSEcCtD
Pimecrolimus—Nervous system disorder—Prednisone—psoriatic arthritis	0.000795	0.00159	CcSEcCtD
Pimecrolimus—Skin disorder—Prednisone—psoriatic arthritis	0.000787	0.00158	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000761	0.00152	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000761	0.00152	CcSEcCtD
Pimecrolimus—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000756	0.00151	CcSEcCtD
Pimecrolimus—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000754	0.00151	CcSEcCtD
Pimecrolimus—Urticaria—Dexamethasone—psoriatic arthritis	0.00074	0.00148	CcSEcCtD
Pimecrolimus—Urticaria—Betamethasone—psoriatic arthritis	0.00074	0.00148	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000739	0.00148	CcSEcCtD
Pimecrolimus—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000736	0.00147	CcSEcCtD
Pimecrolimus—Abdominal pain—Betamethasone—psoriatic arthritis	0.000736	0.00147	CcSEcCtD
Pimecrolimus—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000736	0.00147	CcSEcCtD
Pimecrolimus—Body temperature increased—Betamethasone—psoriatic arthritis	0.000736	0.00147	CcSEcCtD
Pimecrolimus—Paraesthesia—Prednisone—psoriatic arthritis	0.000728	0.00146	CcSEcCtD
Pimecrolimus—Pruritus—Triamcinolone—psoriatic arthritis	0.000726	0.00145	CcSEcCtD
Pimecrolimus—Cough—Methotrexate—psoriatic arthritis	0.000724	0.00145	CcSEcCtD
Pimecrolimus—Pruritus—Methylprednisolone—psoriatic arthritis	0.000724	0.00145	CcSEcCtD
Pimecrolimus—Arthralgia—Methotrexate—psoriatic arthritis	0.000707	0.00141	CcSEcCtD
Pimecrolimus—Rash—Prednisolone—psoriatic arthritis	0.000703	0.00141	CcSEcCtD
Pimecrolimus—Dermatitis—Prednisolone—psoriatic arthritis	0.000703	0.00141	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000702	0.0014	CcSEcCtD
Pimecrolimus—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.0007	0.0014	CcSEcCtD
Pimecrolimus—Headache—Prednisolone—psoriatic arthritis	0.000699	0.0014	CcSEcCtD
Pimecrolimus—Constipation—Prednisone—psoriatic arthritis	0.000693	0.00139	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000678	0.00136	CcSEcCtD
Pimecrolimus—Infection—Methotrexate—psoriatic arthritis	0.000673	0.00135	CcSEcCtD
Pimecrolimus—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000664	0.00133	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000663	0.00133	CcSEcCtD
Pimecrolimus—Nausea—Prednisolone—psoriatic arthritis	0.000663	0.00133	CcSEcCtD
Pimecrolimus—Pruritus—Betamethasone—psoriatic arthritis	0.000659	0.00132	CcSEcCtD
Pimecrolimus—Pruritus—Dexamethasone—psoriatic arthritis	0.000659	0.00132	CcSEcCtD
Pimecrolimus—Skin disorder—Methotrexate—psoriatic arthritis	0.000658	0.00132	CcSEcCtD
Pimecrolimus—Vomiting—Triamcinolone—psoriatic arthritis	0.000652	0.00131	CcSEcCtD
Pimecrolimus—Vomiting—Methylprednisolone—psoriatic arthritis	0.000651	0.0013	CcSEcCtD
Pimecrolimus—Rash—Triamcinolone—psoriatic arthritis	0.000647	0.00129	CcSEcCtD
Pimecrolimus—Dermatitis—Triamcinolone—psoriatic arthritis	0.000646	0.00129	CcSEcCtD
Pimecrolimus—Rash—Methylprednisolone—psoriatic arthritis	0.000645	0.00129	CcSEcCtD
Pimecrolimus—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000645	0.00129	CcSEcCtD
Pimecrolimus—Urticaria—Prednisone—psoriatic arthritis	0.000644	0.00129	CcSEcCtD
Pimecrolimus—Headache—Triamcinolone—psoriatic arthritis	0.000643	0.00129	CcSEcCtD
Pimecrolimus—Headache—Methylprednisolone—psoriatic arthritis	0.000641	0.00128	CcSEcCtD
Pimecrolimus—Abdominal pain—Prednisone—psoriatic arthritis	0.000641	0.00128	CcSEcCtD
Pimecrolimus—Body temperature increased—Prednisone—psoriatic arthritis	0.000641	0.00128	CcSEcCtD
Pimecrolimus—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000637	0.00127	CcSEcCtD
Pimecrolimus—Diarrhoea—Betamethasone—psoriatic arthritis	0.000637	0.00127	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000617	0.00124	CcSEcCtD
Pimecrolimus—Nausea—Triamcinolone—psoriatic arthritis	0.000609	0.00122	CcSEcCtD
Pimecrolimus—Paraesthesia—Methotrexate—psoriatic arthritis	0.000608	0.00122	CcSEcCtD
Pimecrolimus—Nausea—Methylprednisolone—psoriatic arthritis	0.000608	0.00122	CcSEcCtD
Pimecrolimus—Dyspnoea—Methotrexate—psoriatic arthritis	0.000604	0.00121	CcSEcCtD
Pimecrolimus—Hypersensitivity—Prednisone—psoriatic arthritis	0.000597	0.0012	CcSEcCtD
Pimecrolimus—Vomiting—Dexamethasone—psoriatic arthritis	0.000592	0.00118	CcSEcCtD
Pimecrolimus—Vomiting—Betamethasone—psoriatic arthritis	0.000592	0.00118	CcSEcCtD
Pimecrolimus—Rash—Dexamethasone—psoriatic arthritis	0.000587	0.00117	CcSEcCtD
Pimecrolimus—Rash—Betamethasone—psoriatic arthritis	0.000587	0.00117	CcSEcCtD
Pimecrolimus—Dermatitis—Betamethasone—psoriatic arthritis	0.000586	0.00117	CcSEcCtD
Pimecrolimus—Dermatitis—Dexamethasone—psoriatic arthritis	0.000586	0.00117	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000585	0.00117	CcSEcCtD
Pimecrolimus—Headache—Betamethasone—psoriatic arthritis	0.000583	0.00117	CcSEcCtD
Pimecrolimus—Headache—Dexamethasone—psoriatic arthritis	0.000583	0.00117	CcSEcCtD
Pimecrolimus—Pain—Methotrexate—psoriatic arthritis	0.000579	0.00116	CcSEcCtD
Pimecrolimus—Pruritus—Prednisone—psoriatic arthritis	0.000574	0.00115	CcSEcCtD
Pimecrolimus—Diarrhoea—Prednisone—psoriatic arthritis	0.000555	0.00111	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000554	0.00111	CcSEcCtD
Pimecrolimus—Nausea—Dexamethasone—psoriatic arthritis	0.000553	0.00111	CcSEcCtD
Pimecrolimus—Nausea—Betamethasone—psoriatic arthritis	0.000553	0.00111	CcSEcCtD
Pimecrolimus—Urticaria—Methotrexate—psoriatic arthritis	0.000538	0.00108	CcSEcCtD
Pimecrolimus—Abdominal pain—Methotrexate—psoriatic arthritis	0.000536	0.00107	CcSEcCtD
Pimecrolimus—Body temperature increased—Methotrexate—psoriatic arthritis	0.000536	0.00107	CcSEcCtD
Pimecrolimus—Vomiting—Prednisone—psoriatic arthritis	0.000515	0.00103	CcSEcCtD
Pimecrolimus—Rash—Prednisone—psoriatic arthritis	0.000511	0.00102	CcSEcCtD
Pimecrolimus—Dermatitis—Prednisone—psoriatic arthritis	0.000511	0.00102	CcSEcCtD
Pimecrolimus—Headache—Prednisone—psoriatic arthritis	0.000508	0.00102	CcSEcCtD
Pimecrolimus—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000499	0.000999	CcSEcCtD
Pimecrolimus—Nausea—Prednisone—psoriatic arthritis	0.000482	0.000964	CcSEcCtD
Pimecrolimus—Pruritus—Methotrexate—psoriatic arthritis	0.000479	0.000959	CcSEcCtD
Pimecrolimus—Diarrhoea—Methotrexate—psoriatic arthritis	0.000464	0.000928	CcSEcCtD
Pimecrolimus—Vomiting—Methotrexate—psoriatic arthritis	0.000431	0.000862	CcSEcCtD
Pimecrolimus—Rash—Methotrexate—psoriatic arthritis	0.000427	0.000855	CcSEcCtD
Pimecrolimus—Dermatitis—Methotrexate—psoriatic arthritis	0.000427	0.000854	CcSEcCtD
Pimecrolimus—Headache—Methotrexate—psoriatic arthritis	0.000424	0.000849	CcSEcCtD
Pimecrolimus—Nausea—Methotrexate—psoriatic arthritis	0.000402	0.000805	CcSEcCtD
